VanEck Biotech ETF (BBH) Price & Chart
BBH ETF Chart & Stats
- Day’s Range
- $241.86 - $248.78
- 52-Week Range
- $176.30 - $248.78
- Previous Close
- $241.14
- Volume
- 13.30K
- Average Volume (3M)
- 10.06K
- AUM
- 488.52M
- NAV
- 240.88
- Expense Ratio
- 0.35%
- Holdings Count
- 26
- Beta
- 0.59
- Inception Date
- Dec 20, 2011
- Last Dividend Ex-Date
- Dec 22, 2025
- Dividend Yield
- (0.38%)
- Shares Outstanding
- 2,016,503
- Standard Deviation
- N/A
ETF Overview
VanEck Biotech ETF
The VanEck Biotech ETF (BBH) is a targeted investment vehicle designed for those looking to capitalize on the rapid advancements and growth potential within the biotechnology sector, a dynamic niche within the broader health care industry. This ETF is meticulously curated, focusing exclusively on companies at the forefront of biotech innovation, including those involved in the development of new drug therapies, cutting-edge medical technologies, and revolutionary genetic research. By investing in BBH, investors gain exposure to a diversified portfolio of leading biotech firms, from established industry giants to pioneering startups. This positions the ETF as an attractive option for those seeking to participate in the transformative potential of biotechnology, which is driven by scientific breakthroughs and increasing demand for innovative health solutions. The VanEck Biotech ETF not only offers a strategic entry point into the health care sector but also provides an opportunity to benefit from the sector's unique growth trajectory and resilience in the face of global health challenges.